AstraZeneca COVID-19 Vaccine Candidate Moves Into Late-Stage US Clinical Trials With 30,000 Participants
Elon Musk Heads To Germany To Assess Tesla Giga Berlin, Vaccine Printer Progress
FDA Head Says A COVID-19 Vaccine Could Get Emergency Approval Without Phase 3 Trial Results: FT
CanSino, Canada End COVID-19 Vaccine Collaboration, Citing Chinese Bureaucratic Hurdles
Coronavirus Vaccine Recent News
AstraZeneca, Novavax, Pfizer, Others Lobby EU For Legal Protection Against COVID-19 Vaccine Liabilities: FT
Ex-FDA Commissioner Analyzes Johnson & Johnson's Mega Vaccine Trial
Pfizer, BioNTech Say Second Coronavirus Vaccine Shows Fewer Side Effects Than Their First Candidate
CanSino Gets China's First COVID-19 Vaccine Patent
Novavax To Supply 60M Coronavirus Vaccine Doses To UK Under New Deal
AstraZeneca Inks Deal With Mexico, Argentina For Production, Supply Of Its COVID-19 Vaccine To Latin America
Activist Investor Nelson Peltz Says He Is Putting New Capital To Work
Novavax Continues Huge Run, Short Seller Sees It Falling Back To $15